by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
AUSTIN, Texas, July 19, 2016 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the second quarter of 2016. Net loss in Q2 2016 was $3.0 million, or $0.07 per share, compared to a net loss in Q2 2015 of $3.4 million,...
by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
-ZGN-1061 in Phase I Development for Severe and Complicated Obesity Indications- – Suspending Development of Beloranib; Implementing Strategic Restructuring to Align Operations with Clinical Development Priorities- -Strong Cash Position Sufficient to Fund...
by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
HANCOOK, Md., July 19, 2016 (GLOBE NEWSWIRE) — PetLife Pharmaceuticals, Inc. (OTCQB:PTLF), a developer of new generation of high potency veterinary cancer medications and nutraceuticals for pets, today announces it has retained Invicto Group, a leading investors...
by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
Promotes Carol Smith, Ph.D., to Manager of Quality as Part of Manufacturing Optimization Retains Step Change Pharma as Advisor to Strengthen Manufacturing and Technical Infrastructure Retains Former Director of Research & Development, Joseph C. Horvath, M.D., as...
by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
Minneapolis, MN, July 19, 2016 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology information system, today announced it has issued a letter to the Company’s...
